Search contract descriptions, companies and agencies.
TO DEVELOP RAPID AND ACCURATE POINT OF CARE AND OVER THE COUNTER TESTS FOR DETECTION OF SARS-COV-2 ANTIBODIES IN BLOOD AND ACHIEVE EMERGENCY USE AUTHORIZATION (EUA).
Total Committed
$696K
Product or Service Description
Biomedical Advanced Development R&D
Total Potential Value
$696K
Contracting Agency
Effective Date
Aug. 28, 2020
Funding Department
OFC ASST SEC FOR PREPARENESS&RES
Type
Firm fixed price
Solicitation Procedure
Negotiated proposal/quote
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| NOWDIAGNOSTICS, INC. | TO DEVELOP RAPID AND ACCURATE POINT OF CARE AND OVER THE COUNTER TESTS FOR DETECTION OF SARS-COV-2 ANTIBODIES IN BLOOD AND ACHIEVE EMERGENCY USE AUTHORIZATION (EUA). | Aug. 27, 2020 | $695,500 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.